China · Delayed Price · Currency is CNY Double Medical Technology Statistics
Total Valuation
SHE:002901 has a market cap or net worth of CNY 17.09 billion. The enterprise value is 15.80 billion.
| Market Cap | 17.09B |
| Enterprise Value | 15.80B |
Important Dates
The next confirmed earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:002901 has 406.61 million shares outstanding. The number of shares has decreased by -1.68% in one year.
| Current Share Class | 406.61M |
| Shares Outstanding | 406.61M |
| Shares Change (YoY) | -1.68% |
| Shares Change (QoQ) | +1.31% |
| Owned by Insiders (%) | 83.82% |
| Owned by Institutions (%) | 3.73% |
| Float | 65.77M |
Valuation Ratios
The trailing PE ratio is 28.59.
| PE Ratio | 28.59 |
| Forward PE | n/a |
| PS Ratio | 6.57 |
| PB Ratio | 4.64 |
| P/TBV Ratio | 5.04 |
| P/FCF Ratio | 24.48 |
| P/OCF Ratio | 20.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.57, with an EV/FCF ratio of 22.63.
| EV / Earnings | 26.34 |
| EV / Sales | 6.07 |
| EV / EBITDA | 18.57 |
| EV / EBIT | 21.97 |
| EV / FCF | 22.63 |
Financial Position
The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.80 |
| Quick Ratio | 2.32 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 0.45 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 18.55% and return on invested capital (ROIC) is 26.90%.
| Return on Equity (ROE) | 18.55% |
| Return on Assets (ROA) | 9.62% |
| Return on Invested Capital (ROIC) | 26.90% |
| Return on Capital Employed (ROCE) | 17.77% |
| Weighted Average Cost of Capital (WACC) | 5.91% |
| Revenue Per Employee | 577,584 |
| Profits Per Employee | 133,163 |
| Employee Count | 4,503 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 0.61 |
Taxes
In the past 12 months, SHE:002901 has paid 93.17 million in taxes.
| Income Tax | 93.17M |
| Effective Tax Rate | 12.76% |
Stock Price Statistics
The stock price has increased by +18.77% in the last 52 weeks. The beta is 0.32, so SHE:002901's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +18.77% |
| 50-Day Moving Average | 45.00 |
| 200-Day Moving Average | 48.90 |
| Relative Strength Index (RSI) | 40.02 |
| Average Volume (20 Days) | 1,567,935 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002901 had revenue of CNY 2.60 billion and earned 599.63 million in profits. Earnings per share was 1.47.
| Revenue | 2.60B |
| Gross Profit | 1.83B |
| Operating Income | 719.07M |
| Pretax Income | 730.04M |
| Net Income | 599.63M |
| EBITDA | 846.42M |
| EBIT | 719.07M |
| Earnings Per Share (EPS) | 1.47 |
Balance Sheet
The company has 1.72 billion in cash and 313.40 million in debt, with a net cash position of 1.41 billion or 3.46 per share.
| Cash & Cash Equivalents | 1.72B |
| Total Debt | 313.40M |
| Net Cash | 1.41B |
| Net Cash Per Share | 3.46 |
| Equity (Book Value) | 3.69B |
| Book Value Per Share | 8.67 |
| Working Capital | 2.46B |
Cash Flow
In the last 12 months, operating cash flow was 831.34 million and capital expenditures -133.51 million, giving a free cash flow of 697.83 million.
| Operating Cash Flow | 831.34M |
| Capital Expenditures | -133.51M |
| Depreciation & Amortization | 127.35M |
| Net Borrowing | -72.96M |
| Free Cash Flow | 697.83M |
| FCF Per Share | 1.72 |
Margins
Gross margin is 70.50%, with operating and profit margins of 27.65% and 23.06%.
| Gross Margin | 70.50% |
| Operating Margin | 27.65% |
| Pretax Margin | 28.07% |
| Profit Margin | 23.06% |
| EBITDA Margin | 32.54% |
| EBIT Margin | 27.65% |
| FCF Margin | 26.83% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.14%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 1.14% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 35.75% |
| Buyback Yield | 1.68% |
| Shareholder Yield | 2.80% |
| Earnings Yield | 3.51% |
| FCF Yield | 4.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |